Primary |
Pneumonia |
14.0% |
Sinusitis |
13.5% |
Infection |
11.8% |
Bronchitis |
10.9% |
Urinary Tract Infection |
10.9% |
Respiratory Tract Infection |
5.2% |
Upper Respiratory Tract Infection |
4.8% |
Pyrexia |
3.9% |
Pain |
3.5% |
Diabetes Mellitus |
3.1% |
Hypertension |
2.6% |
Lung Infection |
2.2% |
Skin Infection |
2.2% |
Atrial Fibrillation |
1.7% |
Cough |
1.7% |
Diverticulitis |
1.7% |
Prophylaxis |
1.7% |
Pyelonephritis |
1.7% |
Bronchitis Acute |
1.3% |
Cellulitis |
1.3% |
|
Hypoglycaemia |
26.3% |
Hyperglycaemia |
18.2% |
Blood Glucose Increased |
6.7% |
Diabetes Mellitus |
4.8% |
Tremor |
4.8% |
Vomiting |
4.8% |
Renal Failure |
4.3% |
Diabetic Ketoacidosis |
3.3% |
Convulsion |
2.9% |
Rash |
2.9% |
Blood Glucose Decreased |
2.4% |
Blood Glucose Fluctuation |
2.4% |
Hypotension |
2.4% |
Renal Failure Acute |
2.4% |
Sepsis |
2.4% |
Weight Decreased |
2.4% |
Drug Ineffective |
1.9% |
Pneumonia |
1.9% |
Adverse Drug Reaction |
1.4% |
Hypersensitivity |
1.4% |
|
Secondary |
Product Used For Unknown Indication |
15.2% |
Drug Use For Unknown Indication |
9.2% |
Ill-defined Disorder |
8.3% |
Pneumonia |
8.3% |
Bronchitis |
6.9% |
Infection |
6.5% |
Sinusitis |
5.1% |
Upper Respiratory Tract Infection |
5.1% |
Urinary Tract Infection |
5.1% |
Prostatic Disorder |
4.1% |
Respiratory Tract Congestion |
4.1% |
Chronic Obstructive Pulmonary Disease |
3.7% |
Hernia |
2.8% |
Respiratory Disorder |
2.8% |
Sarcoidosis |
2.8% |
Asthma |
2.3% |
Hypertension |
2.3% |
Antiinflammatory Therapy |
1.8% |
Cough |
1.8% |
Inflammation |
1.8% |
|
Visual Acuity Reduced |
16.3% |
Drug Hypersensitivity |
13.8% |
Hypoglycaemia |
12.5% |
Tendonitis |
6.3% |
Hyperglycaemia |
5.0% |
Rotator Cuff Syndrome |
5.0% |
Vomiting |
5.0% |
Choking |
3.8% |
Nausea |
3.8% |
Syncope |
3.8% |
Urticaria |
3.8% |
Arthralgia |
2.5% |
Blood Glucose Increased |
2.5% |
Diabetes Mellitus |
2.5% |
Heart Rate Increased |
2.5% |
Hypotension |
2.5% |
Renal Failure Acute |
2.5% |
Respiratory Failure |
2.5% |
Tendon Rupture |
2.5% |
Blister |
1.3% |
|
Concomitant |
Pain |
18.9% |
Product Used For Unknown Indication |
7.8% |
Hypertension |
6.8% |
Depression |
6.2% |
Colon Cancer Metastatic |
6.0% |
Gastrooesophageal Reflux Disease |
5.5% |
Infection |
4.7% |
Acne |
4.5% |
Menopausal Symptoms |
4.0% |
Sinusitis |
4.0% |
Renal Cell Carcinoma |
3.5% |
Asthma |
3.4% |
Osteoporosis |
3.4% |
Hormone Replacement Therapy |
3.3% |
Multiple Myeloma |
3.3% |
Arthritis |
3.1% |
Prophylaxis |
3.1% |
Hypersensitivity |
3.0% |
Drug Use For Unknown Indication |
2.8% |
Gout |
2.8% |
|
Weight Decreased |
13.8% |
Weight Increased |
10.6% |
Vomiting |
9.0% |
Type 2 Diabetes Mellitus |
8.5% |
Urinary Tract Infection |
5.8% |
Wound Infection |
5.8% |
Wound Dehiscence |
5.3% |
Visual Impairment |
4.8% |
Wound Infection Staphylococcal |
4.8% |
Myocardial Infarction |
3.7% |
Injury |
3.2% |
Renal Failure |
3.2% |
Renal Failure Acute |
3.2% |
Spinal Disorder |
3.2% |
Thrombosis |
3.2% |
Scleroderma |
2.6% |
Tremor |
2.6% |
White Blood Cell Count Decreased |
2.6% |
Drug Exposure During Pregnancy |
2.1% |
Pain |
2.1% |
|